Skip to content

Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR

A Prospective, Multicenter Study to Evaluate the Performance and Safety of CometTM Pressure Guidewire in the Measurement of FFR in Chinese Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04098172
Enrollment
39
Registered
2019-09-23
Start date
2019-09-03
Completion date
2020-03-11
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Brief summary

A prospective, open-label, multi-center study designed to validate the agreement of CometTM Pressure Guidewire and Pressure Wire Certus® in FFR measurements

Detailed description

The COMET China study is a prospective, open-label, multi-center study designed to validate the agreement of CometTM Pressure Guidewire and Pressure Wire Certus® in FFR measurements. Patient with stable angina or any form of non-ST elevation acute coronary syndrome, who are scheduled for diagnostic angiography and pressure wire assessment, and signed the informed consent, will be screened for enrollment in this study.

Interventions

DEVICEPressure Guidewire

Fractional Flow Reserve measurement

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

General Inclusion Criteria: 1. Patient must be at least 18 years old and less than or equal to 75 years of age 2. Patient or his/her legally-authorized representative agrees to sign the EC-approved ICF prior to the procedure 3. Patient with stable angina or any form of non-ST elevation acute coronary syndrome and is clinically indicated of intra-coronary diagnostic angiography and FFR assessment Angiographic Inclusion Criteria: Moderate stenosis (30% to 70% diameter stenosis by visual estimation) is detected at diagnostic angiography General

Exclusion criteria

1. Patients unable to provide informed consent 2. Patients in pregnant state 3. Known renal insufficiency or failure (serum creatinine level of \> 2.5 mg/dL, or on dialysis) 4. Allergy to the contrast 5. Significant arrhythmia, such as II degree or above of atrioventricular block, Sick sinus syndrome, ventricular tachycardia 6. Spastic bronchial asthma 7. ST elevation coronary syndrome 8. Hemodynamic instability 9. Contraindication to nitroglycerin or ATP 10. Current participation in another investigational drug or device clinical study that may affect the FFR measurements Angiographic

Design outcomes

Primary

MeasureTime frameDescription
Fractional Flow Reserve (FFR)during procedure, 1 hourAll eligible subjects will receive FFR measurements simultaneously by both CometTM Pressure Guidewire and Pressure wires Certus®. Fractional flow reserve (FFR) measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. An FFR of 1.0 is widely accepted as normal. An FFR lower than 0.75-0.80 is generally considered to be associated with myocardial ischemia (MI). Agreement between the method of measurement will be confirmed if both conditions are met: The mean paired difference is within +/- 0.005

Countries

China

Participant flow

Participants by arm

ArmCount
Pressure Guidewire Test Subject
Stable patients with suspected or known CAD, who are scheduled for diagnostic angiography and pressure wire assessment, and signed the informed consent, will be screened for enrollment in this study. Pressure Guidewire: Fractional Flow Reserve measurement
39
Total39

Baseline characteristics

CharacteristicPressure Guidewire Test Subject
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
8 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
Age, Continuous58.6 years
STANDARD_DEVIATION 9.2
Medical History
history of Cerebrovascular disease
3 Participants
Medical History
history of Coronary heart disease
37 Participants
Medical History
history of diabetes
9 Participants
Medical History
history of hypertension
24 Participants
Race/Ethnicity, Customized
Chinese han nationality
39 participants
Region of Enrollment
China
39 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
28 Participants
Weight70.9 Kg
STANDARD_DEVIATION 12.7

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
1 / 39
other
Total, other adverse events
0 / 39
serious
Total, serious adverse events
1 / 39

Outcome results

Primary

Fractional Flow Reserve (FFR)

All eligible subjects will receive FFR measurements simultaneously by both CometTM Pressure Guidewire and Pressure wires Certus®. Fractional flow reserve (FFR) measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. An FFR of 1.0 is widely accepted as normal. An FFR lower than 0.75-0.80 is generally considered to be associated with myocardial ischemia (MI). Agreement between the method of measurement will be confirmed if both conditions are met: The mean paired difference is within +/- 0.005

Time frame: during procedure, 1 hour

Population: Pressure guide wire

ArmMeasureValue (GEOMETRIC_MEAN)
Comet Pressure Guidewire Test SubjectFractional Flow Reserve (FFR)0.862 Ratio
Certus Pressure Guidewire Test SubjectFractional Flow Reserve (FFR)0.863 Ratio

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026